SCHEDULE 13G: BlackRock Discloses 5.2% Stake in Semler Scientific Inc.

BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.2% of Semler Scientific Inc.'s common stock as of March 31, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 495,351 shares of Semler Scientific Inc. common stock.
• This represents 5.2% of the total outstanding common shares of Semler Scientific Inc.
• BlackRock holds sole voting power over 491,512 shares and sole dispositive power over 495,351 shares.
• The filing is a Schedule 13G, indicating the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• The beneficial ownership is held by various BlackRock business units, including BlackRock Advisors, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, National Association, BlackRock Financial Management, Inc., and BlackRock Investment Management, LLC.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as a major institutional investor like BlackRock disclosing a significant stake can be viewed favorably by the market, implying confidence in the issuer. However, it's a factual disclosure, not a performance report, so the sentiment is not strongly positive.

Positives

• BlackRock, a major institutional investor, has taken a significant 5.2% stake in Semler Scientific Inc., which can be interpreted as a vote of confidence in the company.
• The filing indicates the shares were acquired in the ordinary course of business, suggesting a long-term investment perspective rather than an activist intent.

Risks

• The document itself does not detail specific risks related to Semler Scientific Inc.'s operations or financial health. It is a disclosure of ownership.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Semler Scientific Inc.'s future performance or outlook.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

This filing is a standard disclosure of institutional ownership and does not provide specific analysis of Semler Scientific Inc.'s position within its industry or broader industry trends.

Stakeholder Impact

• Shareholders: BlackRock's significant stake may instill confidence among existing and potential shareholders, potentially leading to increased investor interest.

Key Dates

Keywords

BlackRock, Semler Scientific Inc., Schedule 13G, beneficial ownership, common stock, institutional investment, equity stake, SEC filing